CSTL Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Castle Biosciences Inc

Watchlist Manager

Watchlist

Price: 32.32 USD 0.03%

Market Cap: $980.3m

	Castle Biosciences Inc NASDAQ:CSTL	US
	Core & Main Inc NYSE:CNM	US
E	Experian PLC XMUN:J2B	IE
M	MS&AD Insurance Group Holdings Inc XBER:59M	JP
O	Omnicell Inc F:OC9	US
	United Microelectronics Corp NYSE:UMC	TW

Profitability Summary

Castle Biosciences Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

77%

Strong 3Y Average Gross Margin

80%

Gross Margin is Increasing

76% > 77%

Negative Operating Margin

-9%

Negative 3Y Average Operating Margin

-12%

Operating Margin is Increasing

-58% > -9%

Negative Net Margin

-5%

Negative 3Y Average Net Margin

-8%

Net Margin is Increasing

-53% > -5%

Negative Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

-31% > 0%

Negative ROE

-4%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-14%

ROIC is Increasing

-52% > -12%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

77%

Strong 3Y Average Gross Margin

80%

Gross Margin is Increasing

76% > 77%

Negative Operating Margin

-9%

Negative 3Y Average Operating Margin

-12%

Operating Margin is Increasing

-58% > -9%